Cooley represented Nuvation Bio in the transaction, and Sidley Austin represented Sagard Healthcare Partners. Nuvation Bio (NYSE: NUVB), a global biopharmaceutical company tackling some of the...
Sagard Healthcare Partners’ $250 Million Non-Dilutive Financings to Nuvation Bio
Avant’s $250 Million Financing from Ares
Cooley advised Avant on the deal. Avant, a credit-first financial technology company, announced that it secured $250 million of corporate debt and redeemable preferred equity from...